Trial intelligence / Profile preview

Alendronate for Wound Healing After Dental Implants in Osteoporosis

NCT00727493Phase 4Unknown

Sponsor
Charité – Universitätsmedizin Berlin
Start
Jan 2004
Primary completion
Jan 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of alendronate in osteoporosis (3 arms), sponsored by Charité – Universitätsmedizin Berlin. Primary endpoint: Dental Computed Tomography at 12 months. Status: unknown.

02

Drugs

alendronate
03

Conditions

osteoporosis

Beyond the preview

Go deeper on NCT00727493.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00727493.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call